The innovative antibody, DISC-0974, exhibits remarkable selectivity for RGMC, this crucial regulator involved with mammalian development. Preclinical studies reveal that inhibiting RGMC/HFE2 function with the molecule https://www.targetmol.com/compound/disc_0974